Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial

This publication has 48 references indexed in Scilit:

• Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2
  New England Journal of Medicine, 2010
• Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load
  AIDS, 2009
• Characteristics of HIV-1 Discordant Couples Enrolled in a Trial of HSV-2 Suppression to Reduce HIV-1 Transmission: The Partners Study
  PLOS ONE, 2009
• Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa
  AIDS, 2009
• Herpes Simplex Virus (HSV)–Suppressive Therapy Decreases Plasma and Genital HIV‐1 Levels in HSV‐2/HIV‐1 Coinfected Women: A Randomized, Placebo‐Controlled, Cross‐Over Trial
  The Journal of Infectious Diseases, 2008
• The Antiherpetic Drug Acyclovir Inhibits HIV Replication and Selects the V75I Reverse Transcriptase Multidrug Resistance Mutation
  Journal of Biological Chemistry, 2008
• Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression
  AIDS, 2008
• Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial
  AIDS, 2008
• Improved Performance of Enzyme-Linked Immunosorbent Assays and the Effect of Human Immunodeficiency Virus Coinfection on the Serologic Detection of Herpes Simplex Virus Type 2 in Rakai, Uganda
  Clinical and Vaccine Immunology, 2008
• Regional Differences in Prevalence of HIV-1 Discordance in Africa and Enrollment of HIV-1 Discordant Couples into an HIV-1 Prevention Trial
  PLOS ONE, 2008